中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 35 Issue 4
Apr.  2019
Turn off MathJax
Article Contents

Clinical effect of ablation in treatment of needle tract implantation after radiofrequency ablation for primary liver cancer

DOI: 10.3969/j.issn.1001-5256.2019.04.021
  • Published Date: 2019-04-20
  • Objective To investigate the risk factors for needle tract implantation after radiofrequency ablation for primary liver cancer and the clinical effect of ablation. Methods A retrospective analysis was performed for the clinical data of 4 patients with needle tract implantation after radiofrequency ablation for primary liver cancer who underwent ablation therapy in Center of Interventional Oncology and Liver Diseases, Beijing You An Hospital, from January 2017 to October 2018. Risk factors, the clinical effect of ablation, and complications were analyzed.Results All four patients had intrahepatic tumor lesions located near the Glisson's capsule, and among these patients, two had poorly differentiated hepatocellular carcinoma ( HCC) , one had moderately differentiated HCC, and one had well-differentiated HCC. The time from radiofrequency ablation to needle tract implantation ranged from 3. 6 to 14. 3 months, and all four patients had a single lesion of needle tract implantation, which was located at the anterior abdominal wall in three patients and at the right abdominal wall in one patient. Of all patients, three underwent argon-helium cryoablation, and one underwent radiofrequency ablation. Two patients experienced pyrexia and transient aggravation of pain after surgery, and the symptoms were relieved after symptomatic treatment. No serious complication was observed. Contrast-enhanced computed tomography performed at one month after surgery showed complete ablation of metastatic lesion in three patients, with no recurrence after follow-up for 2-19 months. One patient was found to have local residual lesion, with marked relief of pain, and no enlargement of the residual lesion was observed after follow-up for 3 months. All patients had significant reductions in serum alpha-fetoprotein and abnormal prothrombin at one month after surgery. Conclusion Ablation therapy, especially argon-helium cryoablation, has a good clinical effect in the treatment of needle tract implantation at the abdominal wall, with the advantages of few complications and good tolerability. Therefore, it is a good choice for patients who cannot tolerate surgical operation or are unwilling to undergo surgical operation.

     

  • loading
  • [1]LI XC, WANG HW, LI CX.Present situation and prospect of comprehensive treatment of hepatocellular carcinoma[J].Chin J Dig Surg, 2018, 17 (5) :433-436. (in Chinese) 李相成, 王宏伟, 李长贤.肝癌综合治疗的现状与展望[J].中华消化外科杂志, 2018, 17 (5) :433-436.
    [2]CHEN Y, ZHOU J, FAN J, et al.Clinical effect and prognostic factors analysis of intraoperative radiofrequency ablation in treatment of hepatocellular carcinoma with severe cirrhosis[J].Chin J Dig Surg, 2017, 16 (2) :159-163. (in Chinese) 陈漪, 周俭, 樊嘉, 等.术中射频消融治疗合并重度肝硬化肝细胞癌的临床疗效及预后因素分析[J].中华消化外科杂志, 2017, 16 (2) :159-163.
    [3]LLOVET JM, VLIANA R, BRU C, et al.Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocelhlar carcinoma[J].Hepatology, 2001, 33 (5) :1124-1129.
    [4]MULIER S, MULIER P, NI Y, et al.Complications of radiofrequency coagulation of liver tumours[J].Br J Surg, 2002, 89 (10) :1206-1222.
    [5] RHIM H, YOON KH, LEE JM, et al.Major complications after Radio-frequency thermal ablation of hepatic tumors:Spectrum of imaging findings[J].Radio Graphics, 2003, 23 (1) :123-136.
    [6]CHANG S, KIM SH, LIM HK, et al.Needle tract implantation after percutaneous interventional procedures in hepatocellular carcinomas:Lessons learned from a 10-year experience[J].Korean J Radiol, 2008, 9 (3) :268-274.
    [7]CHANG S, KIM SH, LIM HK, et al.Needle tract implantation after sonographically guided percutaneous biopsy of hepatocellular carcinoma:Evaluation doubling time, frequency, and features on CT[J].AJR Am J Roentgenol, 2005, 185 (2) :400-405.
    [8]KIM SH, LIM HK, LEE WJ, et al.Needle-tract implantation in hepatocellular carcinoma:Frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun[J].Abdom Imaging, 2000, 25 (3) :246-250.
    [9]ISHII H, OKADA S, OKUSAKA T, et al.Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection[J].Cancer, 1998, 82 (9) :1638-1642.
    [10]ZHANG DK, JI JS, TU JF, et al.A discussion of reasons and methods of prevention and cure for serious complications of radiofrequency ablations in the treatments of hepatocellular carcinomas[J].Chin J Radiol, 2016, 50 (3) :213-216. (in Chinese) 张登科, 纪建松, 涂建飞, 等.射频消融治疗肝癌严重并发症原因分析及其防治方法探讨[J].中华放射学杂志, 2016, 50 (3) :213-216.
    [11]TARANTINO L, FRANCICA G, ESPOSITO F, et al.Seeding from hepatocellular carcinoma after percutaneous ablation:Color Doppler ultrasound findings[J].Abdom Imaging, 2006, 31 (1) :69-77.
    [12]ARRIVE L, VURGAIT A, MONNIER-CHOLLEY L, et al.Long-term follow-up after neoplastic seeding complicating percutaneous ethanol injection for treatment of hepatocellular carcinoma[J].Eur Radiol, 2002, 12 (1) :74-76.
    [13]TAKEMURA N, HASEGAWA K, AOKI T, et al.Surgical resection of peritoneal or thoracoabdominal wall implants from hepatocellular carcinoma[J].Br J Surg, 2014, 101 (8) :1017-1022.
    [14]STIGLIANO R, BURROUGHS AK.Should we biopsy each liver mass suspicious for HCC before liver transplantation?-no, please don’t[J].J Hepatol, 2005, 43 (4) :563-568.
    [15]WU XY, ZHOU JX, ZHOU T, et al.Diagnosis and treatment of neoplastic needle tract seeding following radiofrequency ablation of primary hepatic carcinoma[J].J Hepatobiliary Surg, 2011, 19 (6) :420-422. (in Chinese) 吴星宇, 周建新, 周铁, 等.原发性肝癌冷循环射频治疗术后针道种植转移的诊断与治疗[J].肝胆外科杂志, 2011, 19 (6) :420-422.
    [16]NAKAMURA M, HAYAMI S, UENO M, et al.Detection of needle tract implantation and peritoneal seeding after radiofrequency ablation using intraoperative near-infrared fluorescence system for recurrent hepatocellular carcinoma:A case report[J].Surg Case Rep, 2018, 4 (1) :76.
    [17]SIDANA A, CHOWDHURY WH, FUCHS EJ, et al.Cryoimmunotherapy in urologic oncology[J].Urology, 2010, 75 (5) :1009-1014.
    [18]National Health and Family Planning Commission of the People’s Republic of China.Diagnosis, management, and treatment of hepatocellular carcinoma (V2017) [J].J Clin Heptol, 2017, 33 (8) :1419-1431. (in Chinese) 中华人民共和国国家卫生和计划生育委员会.原发性肝癌诊疗规范 (2017年版) [J].临床肝胆病杂志, 2017, 33 (8) :1419-1431.
    [19]MCDEVITT JL, MOULI SK, NEMCEK AA, et al.Percutaneous cryoablation for the treatment of primary and metastatic lung tumors:Identification of risk factors for recurrence and major complications[J].J Vasc Interv Radiol, 2016, 27 (9) :1371-1379.
    [20]AOUN HD, LITTRUP PJ, JABER M, et al.Percutaneous cryoablation of renal tumors:Is it time for a new paradigm shift?[J].J Vasc Interv Radiol, 2017, 28 (10) :1363-1370.
    [21]JIANG K, TANG K, GUO X, et al.Laparoscopic cryoablation vs.percutaneous cryoablation for treatment of small renal masses:A systematic review and meta-analysis[J].Oncotarget, 2017, 8 (16) :27635-27644.
    [22] NIU LZ, HE LH, ZHOU L, et al.Percutaneous cryoablation and125I seed implantation combined with chemotherapy for advanced pancreatic cancer:Report of 67 cases[J].Chin JOncol, 2012, 34 (12) :940-944. (in Chinese) 牛立志, 何丽华, 周亮, 等.经皮冷消融与125I粒子植入联合化疗治67例晚期胰腺癌的疗效和安全性[J].中华肿瘤杂志, 2012, 34 (12) :940-944.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2047) PDF downloads(313) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return